PDCD1 and colorectal carcinoma: To explain why a minority of MSS CRC patients respond to anti-PD-1 therapy,8 16 we stratified the MSS CRC patients by applying the consensus clustering approach based on gene expression in the six independent pMMR/MSS CRC cohorts.